MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Make-up for Parkinson’s: a randomized control trial

    M. Darabseh, A. Aburub (Amman, Jordan)

  • Making Parkinson’s care complete and global: an international survey of the “vitals” dashboard of Parkinson’s disease

    M. Qamar, C. Falup-Pecurariu, L. Batzu, A. Podlewska, S. Rota, N. Titova, V. Metta, I. Murasan, D. Ziemele, R. van Coller, J. Carr, G. Chung-Faye, L. Ungureanu, K. Ray Chaudhuri (London, United Kingdom)

  • Making the invisible visible: A qualitative interview study on the impact of young onset Parkinson’s disease on (ex-)partners

    W. Kapelle, A. Geerlings, I. Mutsaers, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)

  • Management of constipation in Parkinson’s patients presenting with acute sigmoid volvulus to Royal Berkshire Hospital,Reading, UK

    M. Khwaja, S. Alam, E. Castaneda-Caicedo, A. Chatterjee (Reading, United Kingdom)

  • Management of Sigmoid Volvulus in Parkinson’s patients presenting to Royal Berkshire Hospital, Reading ,UK.

    M. Khwaja, S. Alam, A. Chatterjee, E. Castaneda-Cicedo (Reading, United Kingdom)

  • Manifestations of aging and Parkinson’s Disease in low-frequency fluctuations of postural sway velocity

    M. Latka, K. Kozlowska, A. Latka, M. Glaubic-Latka, S. Budrewicz, M. Koszewicz, T. Sebzda, BJ. West (Wroclaw, Poland)

  • Marked reduction of energy supply due to levodopa treatment in patients with Parkinson’s disease and healthy controls

    J. Prasuhn, T. Schiefen, T. Grüber, J. Hekel, J. Uter, J. Steinhardt, B. Wilms, N. Brüggemann (Lübeck, Germany)

  • May CSF biomarkers have a role in degenerative parkinsonian syndromes workup?

    C. Bernardes, JM. Alves, I. Cunha, D. Carneiro, J. Lemos, F. Moreira, MJ. Leitão, I. Baldeiras, I. Santana, A. Morgadinho (Coimbra, Portugal)

  • MDS-UPDRS III Off Severity Level changes as a marker of DBS response

    S. Castillo-Torres, I. Cruz, M. Rossi, M. Wilken, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

  • MDS-UPDRS Part 3 cannot be summed with other parts of the MDS-UPDRS: a clinimetric evaluation

    C. Goetz, D. Choi, Y. Guo, G. Stebbins, T. Mestre, S. Luo (Chicago, USA)

  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley